AIR LIQUIDE HEALTHCARE AMERICA CORP
PharmaAIR LIQUIDE HEALTHCARE AMERICA CORP is a pharmaceutical company with 1 FDA-approved products.
AIR LIQUIDE HEALTHCARE AMERICA CORP's Key Drugs
AIR LIQUIDE HEALTHCARE AMERICA CORP's core commercial portfolio centers on HELIUM, USP — its most strategically important drugs approved in the last 15 years.
AIR LIQUIDE HEALTHCARE AMERICA CORP's Recent FDA Approvals
New NDA/BLA approvals for AIR LIQUIDE HEALTHCARE AMERICA CORP over the last two years — novel drugs only, excluding generics and label supplements.
AIR LIQUIDE HEALTHCARE AMERICA CORP's Therapeutic Areas
Disease areas where AIR LIQUIDE HEALTHCARE AMERICA CORP has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
AIR LIQUIDE HEALTHCARE AMERICA CORP Pipeline Snapshot
Active clinical trials for AIR LIQUIDE HEALTHCARE AMERICA CORP across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • HELIUM, USP leads revenue
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2013-09-07
- Latest
- 2013-09-07
- Applications
- 1